Salt AI provides the agentic infrastructure layer for the life sciences industry. Its platform allows biopharma companies to deploy, govern, and orchestrate AI agents that can handle complex workflows across drug discovery and clinical operations. Salt AI emphasizes strict compliance (SOC 2, HIPAA) and auditability, solving the 'last mile' problem of integrating generative AI into regulated scientific environments. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.